Contattaci Contact Us

VGFM DATA-LAYER

Event detail:

Moving from umbrella terms to therapeutic features in airway disease: a paradigm shift

18 November 2022 - Day 1

  • Welcome Addresses

    Speaker Markus Ollert

    Session date 18/11/2022 - 08:46

  • Welcome Addresses - The reason for a meeting focused on treatable traits in airway diseases

    Speaker Mario Cazzola

    Session date 18/11/2022 - 09:00

  • Is personalised medicine the key to heterogeneity in airway diseases?

    Speaker Peter J. Barnes

    Session date 18/11/2022 - 09:15

  • Discussion 1

    Speaker -

    Session date 18/11/2022 - 09:30

  • Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic airway diseases

    Speaker Anke-Hilse Maitland-Van der Zee

    Session date 18/11/2022 - 09:50

  • Discussion 2

    Speaker -

    Session date 18/11/2022 - 10:25

  • Treatable traits domains and criteria to be considered a trait

    Speaker Fabio Ricciardolo

    Session date 18/11/2022 - 10:40

  • Discussion 3

    Speaker -

    Session date 18/11/2022 - 10:50

  • Treatable traits as a way toward precision medicine of airway diseases

    Speaker Nicola Scichilone

    Session date 18/11/2022 - 11:30

  • Discussion 4

    Speaker -

    Session date 18/11/2022 - 12:05

  • The importance of the U-BIOPRED project in identifying treatable traits in asthma

    Speaker Kian Fan Chung

    Session date 18/11/2022 - 12:15

  • Discussion 5

    Speaker -

    Session date 18/11/2022 - 12:30

  • The search for new biomarkers to identify treatable traits in airway diseases

    Speaker D. Stolz

    Session date 18/11/2022 - 12:40

  • Discussion 6

    Speaker -

    Session date 18/11/2022 - 13:00

  • Precision medicine and treatable traits in asthma – where do we stand?

    Speaker Charlotte Suppli Ulrik

    Session date 18/11/2022 - 14:15

  • Discussion 7

    Speaker -

    Session date 18/11/2022 - 14:35

  • Can we consider T2high and T2low asthma as treatable traits?

    Speaker Nicola A. Hanania

    Session date 18/11/2022 - 14:50

  • Discussion 8

    Speaker -

    Session date 18/11/2022 - 15:05

  • Precision medicine in united airways disease: A treatable traits approach

    Speaker Tododr A. Popov

    Session date 18/11/2022 - 16:20

  • Discussion 9

    Speaker -

    Session date 18/11/2022 - 16:35

  • ACO: Time to move to the treatable traits

    Speaker Joan Soriano

    Session date 18/11/2022 - 16:55

  • Discussion 10

    Speaker -

    Session date 18/11/2022 - 17:15

  • Panel discussion - The Audience 30 Is there a need for a new taxonomy for airway diseases?

    Speaker Peter J. Barnes

    Session date 18/11/2022 - 17:30

19 November 2022 - Day 2

  • Effectiveness of artificial intelligence for a treatable trait approach in airway diseases

    Speaker L. Calzetta

    Session date 19/11/2022 - 09:00

  • Discussion 11

    Speaker -

    Session date 19/11/2022 - 09:15

  • Alpha-1 antitrypsin deficiency: An underrecognized, treatable trait of airway diseases

    Speaker Miriam Barrecheguren

    Session date 19/11/2022 - 09:35

  • Discussion 12

    Speaker -

    Session date 19/11/2022 - 09:50

  • Are comorbidities treatable traits in airway diseases?

    Speaker Paola Rogliani

    Session date 19/11/2022 - 10:10

  • Discussion 13

    Speaker -

    Session date 19/11/2022 - 10:30

  • Lung microbiome as a treatable trait

    Speaker Andrea Bianco

    Session date 19/11/2022 - 11:15

  • Discussion 14

    Speaker -

    Session date 19/11/2022 - 11:40

  • In search of treatable traits of acute exacerbations of COPD

    Speaker A. G. Mathioudakis

    Session date 19/11/2022 - 11:50

  • Discussion 15

    Speaker -

    Session date 19/11/2022 - 12:15

  • Treatable traits in bronchiectasis

    Speaker C. Crimi

    Session date 19/11/2022 - 12:25

  • Discussion 16

    Speaker -

    Session date 19/11/2022 - 12:45

  • Airway smooth muscle as a treatable trait

    Speaker Maria Gabriella Matera

    Session date 19/11/2022 - 14:00

  • Discussion 17

    Speaker -

    Session date 19/11/2022 - 14:25

  • Eosinophils as a treatable trait

    Speaker Francesca Levi-Schaffer

    Session date 19/11/2022 - 14:35

  • Discussion 18

    Speaker -

    Session date 19/11/2022 - 15:00

  • Current and future targeted therapies for airway diseases

    Speaker Clive Page

    Session date 19/11/2022 - 15:10

  • Diagnosis of stable COPD using the treatable traits concept based on clinical phenotypes

    Speaker Vladimir Koblizek

    Session date 19/11/2022 - 16:15

  • Discussion 19

    Speaker -

    Session date 19/11/2022 - 16:35

  • The use of treatable traits to address COPD complexity and heterogeneity

    Speaker Nicolas Roche

    Session date 19/11/2022 - 16:45

  • Discussion 20

    Speaker -

    Session date 19/11/2022 - 17:10

  • Precision medicine in COPD: from hope to disappointment

    Speaker Pierachille Santus

    Session date 19/11/2022 - 17:15

  • Discussion 21

    Speaker -

    Session date 19/11/2022 - 17:25

  • Treatable traits of airway disease using HRCT

    Speaker E. Kocova

    Session date 19/11/2022 - 17:50

  • Discussion 22

    Speaker -

    Session date 19/11/2022 - 18:15

  • Conclusion and farewell

    Speaker Vladimir Koblizek

    Session date 19/11/2022 - 18:25

Reserved area

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Pills of Art”
A new multimedia project dedicated to the art world.



New Projects: MINUTI DIGITALE



Minuti Menarini Online

Subscribe for free to the paper version of the magazine



Fondazione Menarini



SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Menarini every month.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484